Notably, the expression of AD-related pathogenic markers, including Aβ, tau, and pTau, was significantly reduced in Pep- and NSC-treated cells (Fig. 3u, v, Supplementary Fig. 6c). Here, MAPT is linked to Alzheimer disease.